Acura Pharmaceuticals Provides Update on Opioid Product Licensed to Pfizer
17 oct. 2011 06h00 HE | Acura Pharmaceuticals
PALATINE, IL--(Marketwire - Oct 17, 2011) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company, announced that they have been informed by Pfizer, Inc. (NYSE: PFE) that...